Cargando…
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting October 2019: Impending Change, Innovation, and Future Challenges
The Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI) annual meeting focused on impending change, innovation, and future challenges facing early phase drug development as we move into the second decade of the 21th century. The meeting opened with discussion around the technic...
Autores principales: | Khan, Shahzadgai, Albayaty, Muna, Bush, James, Cheriyan, Joseph, Cromie, Anthea, Koch, Annelize, Hammond, Michael, Mair, Stuart, Lorch, Ulrike, Stringer, Steffan, Taubel, Jorg, Hardman, Timothy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751735/ https://www.ncbi.nlm.nih.gov/pubmed/33364955 http://dx.doi.org/10.3389/fphar.2020.580560 |
Ejemplares similares
-
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development
por: Reijntjes, Susan, et al.
Publicado: (2018) -
Association for Human Pharmacology in the Pharmaceutical Industry conference 2022: impending change, innovations and future challenges
por: Mundy, Charles, et al.
Publicado: (2023) -
EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management
por: Van Bortel, Luc, et al.
Publicado: (2018) -
The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study
por: Ferber, Georg, et al.
Publicado: (2015) -
Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
por: Lorch, Ulrike, et al.
Publicado: (2014)